President Joe Biden has officially signed into law legislation that includes provisions to fund psychedelic studies.

Psilocybin (top left), MDMA (top right), ibogaine (bottom left) and DMT (bottom right).
Last week both the Senate and House of Representatives gave approval to the 2024 National Defense Authorization Act, including provisions that would put millions of dollars into funding the potential medical and therapeutic use of psychedelic substances including psilocybin (“magic mushrooms”) and MDMA (often referred to as ecstasy). President Biden today signed the bill into law.
The psychedelic provisions were introduced by Representative Morgan Littrell (R). Once in effect, they will require the Department of Defense to establish a process for military members who have post traumatic stress disorder (PTSD) or traumatic brain injury to take part in clinical psychedelic trials. In addition to psilocybin and MDMA, the trials could include ibogaine and/or DMT.
Continue reading